OLINER JONATHAN DANIEL
No ORCID on file
· 56 papers in corpus
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …
2011
An antibody specific for angiopoitin-2 (Ang-2), comprising the CDR1, CDR2 and CDR3 from SEQ ID NO: 11 and the CDR1, CDR2 and CDR3 from SEQ ID NO: 12. The antibody can be used for inhibiting undesired angiogenesis or treating one of cancer, …